CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Limited scores highest on Torque (85) and lowest on Earnings (13). Its PosiPenta is 54.87 out of 100, around the middle of similar companies.
On the Penta Grid this week, CSPC Pharmaceutical Group Limited is Grid #2 of 7 in the Healthcare sector in China, and Grid #18 of 58 in China.
Compared with similar companies in the Healthcare sector in China.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| CSPC Pharmaceutical Group Limited | 54.87 | 46 | 13 | 81 | 85 | 49 |
| JD Health International Inc. | 48.56 | 43 | 59 | 35 | 67 | 38 |
| Innovent Biologics, Inc. | 48.08 | 4 | 58 | 78 | 58 | 43 |
| WuXi Biologics (Cayman) Inc. | 53.11 | 15 | 58 | 86 | 68 | 38 |
| Sinopharm Group Co. Ltd. | 52.67 | 95 | 53 | 48 | 24 | 42 |
| Hansoh Pharmaceutical Group Company Limited | 47.56 | 12 | 28 | 59 | 76 | 61 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 12.16 |
| P/B ratio | 2.29 |
EEarnings
| Trailing EPS | ₹8.81 |
| Forward EPS | ₹8.05 |
NNitro
| Price | 107.17 |
| 52-week high | 132.28 |
| 52-week low | 78.81 |
| Fall from 52-week high | 19.0% |
TTorque
| Return on equity (ROE) | 20.90% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 0.71 |
| Market cap | ₹1,22,235 Cr |
| Insider holding | 32.59% |
| Dividend yield | 4.05% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is CSPC Pharmaceutical Group Limited's PosiPenta score?
CSPC Pharmaceutical Group Limited's PosiPenta is 54.87 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does CSPC Pharmaceutical Group Limited stand on the Penta Grid?
On the Penta Grid this week, CSPC Pharmaceutical Group Limited is Grid #2 of 7 in the Healthcare sector in China, and Grid #18 of 58 in China.
Which PosiPenta pillar is strongest for CSPC Pharmaceutical Group Limited?
Torque (durability), with a score of 85 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for CSPC Pharmaceutical Group Limited?
Earnings (growth), with a score of 13 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.